Bausch Health Co. Inc. (BHC) Reports Q1 Revenue of $2.02B

Bausch Health Co. Inc. (NYSE: BHC) reported Q1 EPS of ($0.15), may not compare to the analyst estimate of $0.86. Revenue for the quarter came in at $2.02 billion versus the consensus estimate of $2.03 billion.

• Adjusted EBITDA (non-GAAP)1 of $851 Million

GUIDANCE:

Bausch Health Co. Inc. sees FY2019 revenue of $8.35-8.55 billion, versus the consensus of $8.47 billion.

• Raised Full-Year Adjusted EBITDA (non-GAAP)1 from $3.35 - $3.50 billion to the range of $3.40 – $3.55 billion

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook